Ilaprazole

艾普拉唑

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameIlaprazole
Drug Alias NameNoltecAldenonIY-81149IY-NT-SRIY-NT-R +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsDuodenal UlcerPeptic Ulcer HemorrhageEsophagitis +[4] 
Global Approved IndicationsDuodenal Ulcer
Approved Indications in ChinaDuodenal Ulcer
Original Approved Country/TerritoryMainland China
Original Approved Date2007/12/11
Country/TerritoryUnited StatesSouth KoreaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesIL-Yang Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesIl-Yang Pharmco LtdLivzon(Group) Pharmaceutical Factory
Inactive CompaniesLivzon Pharmaceutical Group IncInje UniversityTakeda Pharmaceutical Co Ltd
Active IndicationsDuodenal Ulcer
Inactive IndicationsPeptic Ulcer HemorrhageEsophagitisGastroesophageal Reflux

Other Information

ATC CodeA02BC
Related LinksWikipediaDrugBankKEGG